Successful treatment of severe atopic dermatitis in a child and an adult with the T-cell modulator efalizumab.
Weinberg
Jeffrey M
JM
Department of Dermatology, St Luke's-Roosevelt Hospital Center and Beth Israel Medical Center, New York, NY, USA.
Siegfried
Elaine C
EC
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; D002648:Child; D003876:Dermatitis, Atopic / Q000175:diagnosis* / Q000188:drug therapy* / Q000473:pathology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007866:Leg; D008297:Male; D008875:Middle Aged; D012720:Severity of Illness Index
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018845:CD11 Antigens; C472181:efalizumab